AbCellera Biologics Inc. (FRA:8QQ)

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $8.96M USD in the quarter ending September 30, 2025, with 37.62% growth. This brings the company's revenue in the last twelve months to $35.33M, up 7.17% year-over-year. In the year 2024, AbCellera Biologics had annual revenue of $28.83M, down -24.17%.

• Revenue (ttm): $35.33M
• Revenue Growth: +7.17%
• P/S Ratio: 29.68
• Revenue / Employee: $59.27K
• Employees: 596
• Market Cap: 893.48M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%